{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:46:40Z","timestamp":1792025200221,"version":"4.4.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"DOI":"10.1007\/s00347-026-02524-7","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:04:13Z","timestamp":1791975853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Morbus Stargardt (ABCA4-assoziierte Retinopathie): \u00dcberblick zu Klinik, Klassifikation und Differenzialdiagnosen","Stargardt disease (ABCA4-asssociated retinopathy): Overview of clinical aspects, classification and differential diagnoses"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1525-2567","authenticated-orcid":false,"given":"Sophia","family":"Dithmar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Lipsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Schargel-Cabezon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Birtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel","family":"Hoyng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Charbel Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Kellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Stingl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank G.","family":"Holz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Pfau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Pfau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"issue":"3","key":"2524_CR1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ng1193-308","volume":"5","author":"J Kaplan","year":"1993","unstructured":"Kaplan\u00a0J et\u00a0al (1993) A\u00a0gene for Stargardt\u2019s disease (fundus flavimaculatus) maps to the short arm of chromosome\u00a01. Nat Genet 5(3):308\u2013311","journal-title":"Nat Genet"},{"issue":"1","key":"2524_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/bjophthalmol-2016-308823","volume":"101","author":"P Tanna","year":"2017","unstructured":"Tanna\u00a0P et\u00a0al (2017) Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options. Br J Ophthalmol 101(1):25\u201330","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"2524_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22096-0","volume":"8","author":"J Birtel","year":"2018","unstructured":"Birtel\u00a0J et\u00a0al (2018) Clinical and genetic characteristics of 251 consecutive patients with macular and cone\/cone-rod dystrophy. Sci Rep 8(1):4824","journal-title":"Sci Rep"},{"key":"2524_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-3-319-95046-4_27","volume":"1085","author":"SH Tsang","year":"2018","unstructured":"Tsang\u00a0SH, Sharma\u00a0T (2018) Stargardt Disease. Adv Exp Med Biol 1085:139\u2013151","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"2524_CR5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1159\/000549368","volume":"68","author":"NL Mata","year":"2025","unstructured":"Mata\u00a0NL et\u00a0al (2025) Bisretinoids as a Source of Early Photoreceptor Pathology in Stargardt Disease. Ophthalmic Res 68(1):555\u2013572","journal-title":"Ophthalmic Res"},{"key":"2524_CR6","doi-asserted-by":"publisher","unstructured":"Lipsy\u00a0T et al https:\/\/doi.org\/10.1007\/s00347-026-02525-6","DOI":"10.1007\/s00347-026-02525-6"},{"key":"2524_CR7","doi-asserted-by":"publisher","unstructured":"Ansari\u00a0G et al https:\/\/doi.org\/10.1007\/s00347-026-02535-4","DOI":"10.1007\/s00347-026-02535-4"},{"key":"2524_CR8","doi-asserted-by":"crossref","unstructured":"Stargardt D.K (1909) \u00dcber famili\u00e4re, progressive Degeneration in der Maculagegend des Auges. Albrecht von Graefe\u2019s Archiv f\u00fcr Ophthalmologie","DOI":"10.1007\/BF01961301"},{"issue":"6","key":"2524_CR9","first-page":"1048","volume":"69","author":"A Franceschetti","year":"1965","unstructured":"Franceschetti\u00a0A (1965) A\u00a0special form of tapetoretinal degeneration: fundus flavimaculatus. Trans Am Acad Ophthalmol Otolaryngol 69(6):1048\u20131053","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"issue":"6","key":"2524_CR10","first-page":"505","volume":"25","author":"A Franceschetti","year":"1965","unstructured":"Franceschetti\u00a0A, Francois\u00a0J (1965) Fundus flavimaculatus. Arch Ophtalmol Rev Gen Ophtalmol 25(6):505\u2013530","journal-title":"Arch Ophtalmol Rev Gen Ophtalmol"},{"issue":"1","key":"2524_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0002-9394(67)93339-9","volume":"64","author":"BA Klien","year":"1967","unstructured":"Klien\u00a0BA, Krill\u00a0AE (1967) Fundus flavimaculatus. Clinical, functional and histopathologic observations. Am J Ophthalmol 64(1):3\u201323","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"2524_CR12","first-page":"396","volume":"56","author":"S Gerber","year":"1995","unstructured":"Gerber\u00a0S et\u00a0al (1995) A gene for late-onset fundus flavimaculatus with macular dystrophy maps to chromosome 1p13. Am J Hum Genet 56(2):396\u2013399","journal-title":"Am J Hum Genet"},{"issue":"6","key":"2524_CR13","first-page":"1351","volume":"57","author":"KL Anderson","year":"1995","unstructured":"Anderson\u00a0KL et\u00a0al (1995) A YAC contig encompassing the recessive Stargardt disease gene (STGD) on chromosome 1p. Am J Hum Genet 57(6):1351\u20131363","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2524_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/ng0997-122b","volume":"17","author":"R Allikmets","year":"1997","unstructured":"Allikmets\u00a0R (1997) A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 17(1):122\u2013122","journal-title":"Nat Genet"},{"issue":"1","key":"2524_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0092-8674(00)80602-9","volume":"98","author":"J Weng","year":"1999","unstructured":"Weng\u00a0J et\u00a0al (1999) Insights into the function of Rim protein in photoreceptors and etiology of Stargardt\u2019s disease from the phenotype in abcr knockout mice. Cell 98(1):13\u201323","journal-title":"Cell"},{"issue":"5","key":"2524_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/hmg\/ddh048","volume":"13","author":"AV Cideciyan","year":"2004","unstructured":"Cideciyan\u00a0AV et\u00a0al (2004) Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet 13(5):525\u2013534","journal-title":"Hum Mol Genet"},{"issue":"14","key":"2524_CR17","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/hmg\/ddab122","volume":"30","author":"W Lee","year":"2021","unstructured":"Lee\u00a0W et\u00a0al (2021) Cis-acting modifiers in the ABCA4 locus contribute to the penetrance of the major disease-causing variant in Stargardt disease. Hum Mol Genet 30(14):1293\u20131304","journal-title":"Hum Mol Genet"},{"issue":"7","key":"2524_CR18","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41431-020-0581-4","volume":"28","author":"JS Green","year":"2020","unstructured":"Green\u00a0JS et\u00a0al (2020) The genetic architecture of Stargardt macular dystrophy (STGD1): a longitudinal 40-year study in a genetic isolate. Eur J Hum Genet 28(7):925\u2013937","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"2524_CR19","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0161-6420(87)33533-X","volume":"94","author":"GA Fishman","year":"1987","unstructured":"Fishman\u00a0GA et\u00a0al (1987) Visual acuity loss in patients with Stargardt\u2019s macular dystrophy. Ophthalmology 94(7):809\u2013814","journal-title":"Ophthalmology"},{"issue":"8","key":"2524_CR20","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.ophtha.2024.01.035","volume":"131","author":"BJ Fenner","year":"2024","unstructured":"Fenner\u00a0BJ et\u00a0al (2024) A Retrospective Longitudinal Study of 460 Patients with ABCA4-Associated Retinal Disease. Ophthalmology 131(8):985\u2013997","journal-title":"Ophthalmology"},{"issue":"6","key":"2524_CR21","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0161-6420(03)00333-6","volume":"110","author":"Y Rotenstreich","year":"2003","unstructured":"Rotenstreich\u00a0Y, Fishman\u00a0GA, Anderson\u00a0RJ (2003) Visual acuity loss and clinical observations in a large series of patients with Stargardt disease. Ophthalmology 110(6):1151\u20131158","journal-title":"Ophthalmology"},{"issue":"3","key":"2524_CR22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S0161-6420(98)93026-3","volume":"105","author":"JD Armstrong","year":"1998","unstructured":"Armstrong\u00a0JD et\u00a0al (1998) Long-term follow-up of Stargardt\u2019s disease and fundus flavimaculatus. Ophthalmology 105(3):448\u2013457 (discussion 457-8)","journal-title":"Ophthalmology"},{"issue":"3","key":"2524_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ajo.2013.05.003","volume":"156","author":"K Fujinami","year":"2013","unstructured":"Fujinami\u00a0K et\u00a0al (2013) Clinical and molecular analysis of Stargardt disease with preserved foveal structure and function. Am J Ophthalmol 156(3):487\u2013501 e1","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"2524_CR24","doi-asserted-by":"publisher","first-page":"7355","DOI":"10.1167\/iovs.14-15317","volume":"55","author":"RA van Huet","year":"2014","unstructured":"van Huet\u00a0RA et\u00a0al (2014) The RD5000 database: facilitating clinical, genetic, and therapeutic studies on inherited retinal diseases. Invest Ophthalmol Vis Sci 55(11):7355\u20137360","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2524_CR25","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ajo.2025.07.024","volume":"279","author":"J Pas","year":"2025","unstructured":"Pas\u00a0J et\u00a0al (2025) The Visual Acuity Course in Stargardt Disease. Am J Ophthalmol 279:234\u2013241","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"2524_CR26","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00417-019-04280-8","volume":"257","author":"NM Bax","year":"2019","unstructured":"Bax\u00a0NM et\u00a0al (2019) The absence of fundus abnormalities in Stargardt disease. Graefes Arch Clin Exp Ophthalmol 257(6):1147\u20131157","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"2524_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1001\/archophthalmol.2011.332","volume":"130","author":"CA Cukras","year":"2012","unstructured":"Cukras\u00a0CA et\u00a0al (2012) Centrifugal expansion of fundus autofluorescence patterns in Stargardt disease over time. Arch Ophthalmol 130(2):171\u2013179","journal-title":"Arch Ophthalmol"},{"issue":"26","key":"2524_CR28","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/j.visres.2008.01.010","volume":"48","author":"CJ Boon","year":"2008","unstructured":"Boon\u00a0CJ et\u00a0al (2008) Fundus autofluorescence imaging of retinal dystrophies. Vision Res 48(26):2569\u20132577","journal-title":"Vision Res"},{"issue":"12","key":"2524_CR29","doi-asserted-by":"publisher","first-page":"4739","DOI":"10.1167\/iovs.05-0805","volume":"46","author":"AV Cideciyan","year":"2005","unstructured":"Cideciyan\u00a0AV et\u00a0al (2005) ABCA4-associated retinal degenerations spare structure and function of the human parapapillary retina. Invest Ophthalmol Vis Sci 46(12):4739\u20134746","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2524_CR30","doi-asserted-by":"crossref","unstructured":"Kellner S et\u00a0al (2024) Near-Infrared Autofluorescence: Early Detection of Retinal Pigment Epithelial Alterations in Inherited Retinal Dystrophies. J\u00a0Clin Med 13(22).","DOI":"10.3390\/jcm13226886"},{"issue":"6","key":"2524_CR31","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.8.6.46","volume":"8","author":"PL Muller","year":"2019","unstructured":"Muller\u00a0PL et\u00a0al (2019) Functional Relevance and Structural Correlates of Near Infrared and Short Wavelength Fundus Autofluorescence Imaging in ABCA4-Related Retinopathy. Transl Vis Sci Technol 8(6):46","journal-title":"Transl Vis Sci Technol"},{"issue":"7","key":"2524_CR32","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.oret.2020.02.009","volume":"4","author":"M Gliem","year":"2020","unstructured":"Gliem\u00a0M et\u00a0al (2020) Quantitative Fundus Autofluorescence and Genetic Associations in Macular, Cone, and Cone-Rod Dystrophies. Ophthalmol Retina 4(7):737\u2013749","journal-title":"Ophthalmol Retina"},{"key":"2524_CR33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ajo.2020.08.042","volume":"222","author":"PL Muller","year":"2021","unstructured":"Muller\u00a0PL et\u00a0al (2021) Quantitative Fundus Autofluorescence in ABCA4-Related Retinopathy -Functional Relevance and Genotype-Phenotype Correlation. Am J Ophthalmol 222:340\u2013350","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"2524_CR34","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1167\/iovs.12-11490","volume":"54","author":"JR Sparrow","year":"2013","unstructured":"Sparrow\u00a0JR et\u00a0al (2013) Quantitative fundus autofluorescence in mice: correlation with HPLC quantitation of RPE lipofuscin and measurement of retina outer nuclear layer thickness. Invest Ophthalmol Vis Sci 54(4):2812\u20132820","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2524_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100893","volume":"81","author":"S Schmitz-Valckenberg","year":"2021","unstructured":"Schmitz-Valckenberg\u00a0S et\u00a0al (2021) Fundus autofluorescence imaging. Prog Retin Eye Res 81:100893","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"2524_CR36","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.12.2.1","volume":"12","author":"PPA Dhooge","year":"2023","unstructured":"Dhooge\u00a0PPA et\u00a0al (2023) Repeatability of Quantitative Autofluorescence Imaging in a Multicenter Study Involving Patients With Recessive Stargardt Disease 1. Transl Vis Sci Technol 12(2):1","journal-title":"Transl Vis Sci Technol"},{"issue":"11","key":"2524_CR37","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.66.11.12","volume":"66","author":"DA Merle","year":"2025","unstructured":"Merle\u00a0DA et\u00a0al (2025) Flavoprotein Fluorescence Imaging in Stargardt Disease: Linking Metabolic Stress to Structural Damage. Invest Ophthalmol Vis Sci 66(11):12","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"2524_CR38","doi-asserted-by":"publisher","first-page":"5946","DOI":"10.1167\/iovs.15-17698","volume":"56","author":"AV Cideciyan","year":"2015","unstructured":"Cideciyan\u00a0AV et\u00a0al (2015) Predicting Progression of ABCA4-Associated Retinal Degenerations Based on Longitudinal Measurements of the Leading Disease Front. Invest Ophthalmol Vis Sci 56(10):5946\u20135955","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"2524_CR39","doi-asserted-by":"publisher","first-page":"7217","DOI":"10.1167\/iovs.14-14674","volume":"55","author":"K Noupuu","year":"2014","unstructured":"Noupuu\u00a0K et\u00a0al (2014) Structural and genetic assessment of the ABCA4-associated optical gap phenotype. Invest Ophthalmol Vis Sci 55(11):7217\u20137226","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2524_CR40","doi-asserted-by":"crossref","unstructured":"Pfau M et\u00a0al (2022) Photoreceptor degeneration in ABCA4-associated retinopathy and its genetic correlates. JCI Insight 7(2).","DOI":"10.1172\/jci.insight.155373"},{"issue":"4","key":"2524_CR41","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ophtha.2015.12.009","volume":"123","author":"RW Strauss","year":"2016","unstructured":"Strauss\u00a0RW et\u00a0al (2016) The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1. Ophthalmology 123(4):817\u2013828","journal-title":"Ophthalmology"},{"issue":"10","key":"2524_CR42","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1001\/jamaophthalmol.2019.2885","volume":"137","author":"RW Strauss","year":"2019","unstructured":"Strauss\u00a0RW et\u00a0al (2019) Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a\u00a012-Month Period: ProgStar Report No. 11. JAMA Ophthalmol 137(10):1134\u20131145","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"2524_CR43","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.7.5.13","volume":"7","author":"PL Muller","year":"2018","unstructured":"Muller\u00a0PL et\u00a0al (2018) Comparison of Green Versus Blue Fundus Autofluorescence in ABCA4-Related Retinopathy. Transl Vis Sci Technol 7(5):13","journal-title":"Transl Vis Sci Technol"},{"issue":"12","key":"2524_CR44","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1097\/IAE.0000000000002747","volume":"40","author":"PL Muller","year":"2020","unstructured":"Muller\u00a0PL et\u00a0al (2020) PROGRESSION OF ABCA4-RELATED RETINOPATHY: Prognostic value of demographic, functional, genetic, and imaging parameters. Retina 40(12):2343\u20132356","journal-title":"Retina"},{"issue":"12","key":"2524_CR45","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1001\/archopht.1976.03910040721003","volume":"94","author":"GA Fishman","year":"1976","unstructured":"Fishman\u00a0GA (1976) Fundus flavimaculatus. A\u00a0clinical classification. Arch Ophthalmol 94(12):2061\u20132067","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"2524_CR46","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1001\/archopht.119.3.359","volume":"119","author":"N Lois","year":"2001","unstructured":"Lois\u00a0N et\u00a0al (2001) Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol 119(3):359\u2013369","journal-title":"Arch Ophthalmol"},{"key":"2524_CR47","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ajo.2023.05.014","volume":"253","author":"M Pfau","year":"2023","unstructured":"Pfau\u00a0M et\u00a0al (2023) Natural History of Visual Dysfunction in ABCA4 Retinopathy and Its Genetic Correlates. Am J Ophthalmol 253:224\u2013232","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"2524_CR48","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.11.9.34","volume":"11","author":"SL Glinton","year":"2022","unstructured":"Glinton\u00a0SL et\u00a0al (2022) Phenotyping of ABCA4 Retinopathy by Machine Learning Analysis of Full-Field Electroretinography. Transl Vis Sci Technol 11(9):34","journal-title":"Transl Vis Sci Technol"},{"issue":"5","key":"2524_CR49","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00417-023-06292-x","volume":"262","author":"J Pas","year":"2024","unstructured":"Pas\u00a0J, Dhooge\u00a0PPA, Hoyng\u00a0CB (2024) Clinical classification of Stargardt disease. Graefes Arch Clin Exp Ophthalmol 262(5):1377\u20131379","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"2524_CR50","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1086\/303090","volume":"67","author":"A Rivera","year":"2000","unstructured":"Rivera\u00a0A et\u00a0al (2000) A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. Am J Hum Genet 67(4):800\u2013813","journal-title":"Am J Hum Genet"},{"issue":"8","key":"2524_CR51","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1167\/iovs.18-23881","volume":"59","author":"EH Runhart","year":"2018","unstructured":"Runhart\u00a0EH et\u00a0al (2018) The Common ABCA4 Variant p.Asn1868Ile Shows Nonpenetrance and Variable Expression of Stargardt Disease When Present in trans With Severe Variants. Invest Ophthalmol Vis Sci 59(8):3220\u20133231","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"13","key":"2524_CR52","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.1167\/iovs.18-25579","volume":"59","author":"R Allikmets","year":"2018","unstructured":"Allikmets\u00a0R, Zernant\u00a0J, Lee\u00a0W (2018) Penetrance of the ABCA4 p.Asn1868Ile Allele in Stargardt Disease. Invest Ophthalmol Vis Sci 59(13):5564\u20135565","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"2524_CR53","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/jmedgenet-2017-104540","volume":"54","author":"J Zernant","year":"2017","unstructured":"Zernant\u00a0J et\u00a0al (2017) Frequent hypomorphic alleles account for a significant fraction of ABCA4 disease and distinguish it from age-related macular degeneration. J\u00a0Med Genet 54(6):404\u2013412","journal-title":"J Med Genet"},{"issue":"1","key":"2524_CR54","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","volume":"7","author":"M Fleckenstein","year":"2021","unstructured":"Fleckenstein\u00a0M et\u00a0al (2021) Age-related macular degeneration. Nat Rev Dis Primers 7(1):31\u201331","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"2524_CR55","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ophtha.2023.08.011","volume":"131","author":"CHZ Li","year":"2024","unstructured":"Li\u00a0CHZ et\u00a0al (2024) Study of Late-Onset Stargardt Type 1 Disease: Characteristics, Genetics, and Progression. Ophthalmology 131(1):87\u201397","journal-title":"Ophthalmology"},{"issue":"10","key":"2524_CR56","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jamaophthalmol.2020.2990","volume":"138","author":"EH Runhart","year":"2020","unstructured":"Runhart\u00a0EH et\u00a0al (2020) Association of Sex With Frequent and Mild ABCA4 Alleles in Stargardt Disease. JAMA Ophthalmol 138(10):1035\u20131042","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"2524_CR57","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1167\/iovs.16-20980","volume":"58","author":"M Lindner","year":"2017","unstructured":"Lindner\u00a0M et\u00a0al (2017) Differential Disease Progression in Atrophic Age-Related Macular Degeneration and Late-Onset Stargardt Disease. Invest Ophthalmol Vis Sci 58(2):1001\u20131007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2524_CR58","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/978-3-031-27681-1_42","volume":"1415","author":"M Pfau","year":"2023","unstructured":"Pfau\u00a0M et\u00a0al (2023) Genotype-Phenotype Association in ABCA4-Associated Retinopathy. Adv Exp Med Biol 1415:289\u2013295","journal-title":"Adv Exp Med Biol"},{"key":"2524_CR59","doi-asserted-by":"crossref","unstructured":"Lee W et\u00a0al (2022) A\u00a0genotype-phenotype correlation matrix for ABCA4 disease based on long-term prognostic outcomes. JCI Insight 7(2)","DOI":"10.1172\/jci.insight.156154"},{"issue":"3","key":"2524_CR60","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/sj.ejhg.5200221","volume":"6","author":"JM Rozet","year":"1998","unstructured":"Rozet\u00a0JM et\u00a0al (1998) Spectrum of ABCR gene mutations in autosomal recessive macular dystrophies. Eur J Hum Genet 6(3):291\u2013295","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"2524_CR61","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1001\/archopht.117.4.504","volume":"117","author":"GA Fishman","year":"1999","unstructured":"Fishman\u00a0GA et\u00a0al (1999) Variation of clinical expression in patients with Stargardt dystrophy and sequence variations in the ABCR gene. Arch Ophthalmol 117(4):504\u2013510","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"2524_CR62","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s00417-002-0502-y","volume":"240","author":"C Gerth","year":"2002","unstructured":"Gerth\u00a0C et\u00a0al (2002) Phenotypes of 16 Stargardt macular dystrophy\/fundus flavimaculatus patients with known ABCA4 mutations and evaluation of genotype-phenotype correlation. Graefes Arch Clin Exp Ophthalmol 240(8):628\u2013638","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"2524_CR63","doi-asserted-by":"publisher","first-page":"7274","DOI":"10.1167\/iovs.15-17371","volume":"56","author":"T Duncker","year":"2015","unstructured":"Duncker\u00a0T et\u00a0al (2015) Quantitative Fundus Autofluorescence and Optical Coherence Tomography in ABCA4 Carriers. Invest Ophthalmol Vis Sci 56(12):7274\u20137285","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"2524_CR64","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1093\/hmg\/ddn421","volume":"18","author":"AV Cideciyan","year":"2009","unstructured":"Cideciyan\u00a0AV et\u00a0al (2009) ABCA4 disease progression and a proposed strategy for gene therapy. Hum Mol Genet 18(5):931\u2013941","journal-title":"Hum Mol Genet"},{"issue":"12","key":"2524_CR65","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1136\/bjo.2007.118356","volume":"91","author":"M Michaelides","year":"2007","unstructured":"Michaelides\u00a0M et\u00a0al (2007) ABCA4 mutations and discordant ABCA4 alleles in patients and siblings with bull\u2019s-eye maculopathy. Br J Ophthalmol 91(12):1650\u20131655","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"2524_CR66","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.exer.2009.02.001","volume":"89","author":"W Cella","year":"2009","unstructured":"Cella\u00a0W et\u00a0al (2009) G1961E mutant allele in the Stargardt disease gene ABCA4 causes bull\u2019s eye maculopathy. Exp Eye Res 89(1):16\u201324","journal-title":"Exp Eye Res"},{"issue":"13","key":"2524_CR67","doi-asserted-by":"publisher","first-page":"8181","DOI":"10.1167\/iovs.13-12104","volume":"54","author":"K Fujinami","year":"2013","unstructured":"Fujinami\u00a0K et\u00a0al (2013) A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations. Invest Ophthalmol Vis Sci 54(13):8181\u20138190","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"2524_CR68","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.67.2.32","volume":"67","author":"J Pas","year":"2026","unstructured":"Pas\u00a0J et\u00a0al (2026) Genetic Correlates of Phenotypic Variability in c.5882G\u3009A p.(Gly1961Glu)-Associated Stargardt Disease. Invest Ophthalmol Vis Sci 67(2):32","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"2524_CR69","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1001\/archopht.1980.01020040637010","volume":"98","author":"GW Cibis","year":"1980","unstructured":"Cibis\u00a0GW, Morey\u00a0M, Harris\u00a0DJ (1980) Dominantly inherited macular dystrophy with flecks (Stargardt). Arch Ophthalmol 98(10):1785\u20131789","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"2524_CR70","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S0161-6420(90)32508-3","volume":"97","author":"PF Lopez","year":"1990","unstructured":"Lopez\u00a0PF et\u00a0al (1990) Autosomal-dominant fundus flavimaculatus. Clinicopathologic correlation. Ophthalmology 97(6):798\u2013809","journal-title":"Ophthalmology"},{"issue":"1","key":"2524_CR71","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/83817","volume":"27","author":"K Zhang","year":"2001","unstructured":"Zhang\u00a0K et\u00a0al (2001) A 5\u2011bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genet 27(1):89\u201393","journal-title":"Nat Genet"},{"issue":"37","key":"2524_CR72","doi-asserted-by":"publisher","first-page":"32521","DOI":"10.1074\/jbc.M503411200","volume":"280","author":"C Grayson","year":"2005","unstructured":"Grayson\u00a0C, Molday\u00a0RS (2005) Dominant negative mechanism underlies autosomal dominant Stargardt-like macular dystrophy linked to mutations in ELOVL4. J\u00a0Biol Chem 280(37):32521\u201332530","journal-title":"J Biol Chem"},{"key":"2524_CR73","doi-asserted-by":"crossref","unstructured":"Buhler VMM et\u00a0al (2021) Absence of Genotype\/Phenotype Correlations Requires Molecular Diagnostic to Ascertain Stargardt and Stargardt-Like Swiss Patients. Genes (Basel) 12(6)","DOI":"10.3390\/genes12060812"},{"issue":"5","key":"2524_CR74","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1086\/302377","volume":"64","author":"M Kniazeva","year":"1999","unstructured":"Kniazeva\u00a0M et\u00a0al (1999) A new locus for autosomal dominant stargardt-like disease maps to chromosome 4. Am J Hum Genet 64(5):1394\u20131399","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2524_CR75","doi-asserted-by":"publisher","first-page":"122","DOI":"10.18632\/oncotarget.22343","volume":"9","author":"S Imani","year":"2018","unstructured":"Imani\u00a0S et\u00a0al (2018) Genetic identification and molecular modeling characterization reveal a\u00a0novel PROM1 mutation in Stargardt4-like macular dystrophy. Oncotarget 9(1):122\u2013141","journal-title":"Oncotarget"},{"issue":"38","key":"2524_CR76","doi-asserted-by":"publisher","first-page":"13953","DOI":"10.1074\/jbc.RA119.008618","volume":"294","author":"Z Lu","year":"2019","unstructured":"Lu\u00a0Z et\u00a0al (2019) Deletion of the transmembrane protein Prom1b in zebrafish disrupts outer-segment morphogenesis and causes photoreceptor degeneration. J\u00a0Biol Chem 294(38):13953\u201313963","journal-title":"J Biol Chem"},{"issue":"3","key":"2524_CR77","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/ng0393-213","volume":"3","author":"J Wells","year":"1993","unstructured":"Wells\u00a0J et\u00a0al (1993) Mutations in the human retinal degeneration slow (RDS) gene can cause either retinitis pigmentosa or macular dystrophy. Nat Genet 3(3):213\u2013218","journal-title":"Nat Genet"},{"issue":"12","key":"2524_CR78","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.66.12.53","volume":"66","author":"E Van Vooren","year":"2025","unstructured":"Van Vooren\u00a0E et\u00a0al (2025) RPE65 Variant p.(E519K) Causes a Novel Dominant Adult-Onset Maculopathy in 83 Affected Individuals. Invest Ophthalmol Vis Sci 66(12):53","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"2524_CR79","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ajhg.2025.02.015","volume":"112","author":"K Kaminska","year":"2025","unstructured":"Kaminska\u00a0K et\u00a0al (2025) Bi-allelic variants in three genes encoding distinct subunits of the vesicular AP\u20115 complex cause hereditary macular dystrophy. Am J Hum Genet 112(4):808\u2013828","journal-title":"Am J Hum Genet"},{"key":"2524_CR80","doi-asserted-by":"crossref","unstructured":"Sajovic J et\u00a0al (2023) Stargardt-like Clinical Characteristics and Disease Course Associated with Variants in the WDR19 Gene. Genes (Basel) 14(2)","DOI":"10.3390\/genes14020291"},{"issue":"3","key":"2524_CR81","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/a-2533-1009","volume":"242","author":"M Gerhardt","year":"2025","unstructured":"Gerhardt\u00a0M, Stingl\u00a0K, Reith\u00a0M (2025) Pharmacotherapy of ABCA4-associated Retinal Dystrophies. Klin Monbl Augenheilkd 242(3):205\u2013212","journal-title":"Klin Monbl Augenheilkd"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-026-02524-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-026-02524-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-026-02524-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:07:16Z","timestamp":1792022836000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-026-02524-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":81,"alternative-id":["2524"],"URL":"https:\/\/doi.org\/10.1007\/s00347-026-02524-7","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"9 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.\u00a0Dithmar, T.\u00a0Lipsky, E.\u00a0Schargel-Cabezon, J.\u00a0Birtel, C.\u00a0Hoyng und P.\u00a0Charbel Issa geben an, dass kein Interessenskonflikt besteht. U.\u00a0Kellner erkl\u00e4rt, dass er Beratungshonorare von Apellis Germany GmbH, Astellas Pharma GmbH, Bayer Vital GmbH, Chiesi GmbH, Novartis GmbH, Roche GmbH, Rhythm Pharmaceuticals Germany GmbH und Sandoz DE\/Hexal AG erhielt, sowie Honorare f\u00fcr Vortr\u00e4ge, Pr\u00e4sentationen, T\u00e4tigkeiten im Speakers\u00b4Bureaus, Erstellung von Manuskripten und Mitwirkung an Forschungsveranstaltungen von AbbVie GmbH, Apellis Germany GmbH, Bayer Vital GmbH, Heidelberg Engineering GmbH und Novartis GmbH, die nicht in Zusammenhang mit den Inhalten dieses Artikels stehen. Er gibt weiterhin an, unbezahlter Vorsitzender in der Vereinigung Operierender Augen\u00e4rzte Nordrhein, unbezahltes Vorstandsmitglied von Ocunet, unbezahltes Mitglied des wissenschaftlichen und Vorsitzender des klinischen Beirats von Pro Retina Deutschland e.\u202fV. zu sein, unbezahlt an der Entwicklung von Leitlinien der Deutschen Ophthalmologischen Gesellschaft mitzuwirken sowie Vorsitzender der UDRBK GmBH zu sein. K.\u00a0Stingl gibt an, an die Institution gezahlte F\u00f6rdermittel von Kerstan foundation, Deutscher Forschungsgemeinschaft, Orphan Disease Center\/Univ. of Pennsylvania, Dieter-Schwarz-Stiftung, Stiftung f\u00fcr Medizininnovationen und BCM Foundation erhalten zu haben, sowie Beratungshonoare von Novartis GmbH, ProQR Therapeutics, ViGeneron, Santen, Janssen, Lundbeck, THEA, RhyGaze und Asidian, die nicht in Zusammenhang mit den Inhalten dieses Artikels stehen. Sie erhielt weiterhin Zahlungen f\u00fcr gutachterliche T\u00e4tigkeiten von den Zentren f\u00fcr seltene Erkrankungen in Wien und Graz (\u00d6sterreich), Reisekostenunterst\u00fctzung (THEA SepulBIO 2025), ist Mitglied in wissenschaftlichen Beir\u00e4ten von ProQR, THEA, Ascidian und wissenschaftlichem Beirat des Institute de la Vision, Paris, Leiterin der Arbeitsgruppe und HCP des Europ\u00e4ischen Referenznetzwerks f\u00fcr seltene Augenerkrankungen, Leiterin der Sektion Genetik der Deutschen Ophthalmologischen Gesellschaft, nationaler Koordinator und HCP des Deutschen Referenznetzwerks f\u00fcr seltene Augenerkrankungen und Mitglied der Expertengruppe von EVICR.net. F.G.\u00a0Holz erkl\u00e4rt, Zuwendungen von Acucela, Apellis Pharmaceuticals, Astellas, Bayer Healthcare Pharmaceuticals Inc., Carl Zeiss, F. Hoffmann-La Roche\/Genentech, Heidelberg Engineering, Inc., Novartis Pharma AG und Science Corporation, Beratungshonorare von Acucela, Apellis, Astellas Pharma, Boehringer Ingelheim, Carl Zeiss, F. Hoffmann-La Roche, Heidelberg Engineering, Inc. und Science Corporation, sowie Honorare f\u00fcr Vortr\u00e4ge, Pr\u00e4sentationen o. \u00e4. von Acucela, Apellis, Astellas, Boerhinger Ingelheim, Carl Zeiss, F. Hoffmann-La Roche und Heidelberg Engineering, Inc. Er ist weiterhin unbezahltes Vorstandsmitglied und Mitglied des Ausschusses f\u00fcr Makulaerkrankungen der DOG und bezahlter Direktor des Grade Reading Centers. K.\u00a0Pfau erhielt Beratungskonorare von Daichi Sanyo, F\u00f6rdermittel von iCare, Bayer und Inozyme sowie Reisekostenunterst\u00fctzung von Bayer, Heidelberg Engineering und F. Hoffmann-La Roche. Sie ist Mitglied des wissenschaftlichen Beirats von F. Hoffmann-La Roche, Mitglied des Lenkungsausschusses der NAC Attack Study, kooptiertes Vorstandsmitglied von EURETINA sowie Mitglied des YOURS-Komitees. M.\u00a0Pfau gibt an, Beratungshonorare von Apellis und Roche, sowie F\u00f6rdermittel von iCare\/Center Aue erhalten zu haben, welche in keinem Zusammenhang mit den Inhalten dieses Artikels stehen.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}